Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-Associated Antigen Presented by Major Histocompatibility Complex (TAA-MHC)
- Target
- TAA-MHC
- Molecular classification
- Peptide-MHC Complex, Antigen Presentation Molecule, Cell Surface Receptor Ligand
01
Overview
A tumor-associated antigen (TAA) presented by the major histocompatibility complex (MHC) refers to a molecule or peptide derived from tumor cells that is displayed on the cell surface in association with MHC molecules. This presentation is crucial for immune recognition and targeting of cancer cells. The complex is recognized by T cell receptors on T lymphocytes, leading to an immune response. Loss or downregulation of MHC molecules is a major mechanism of immune evasion in cancer.
- Other names
- TAA presented by MHCTumor antigen-MHC complexMHC-presented TAA
02
Mechanism of action
Enhances T cell recognition and killing of tumor cells; blocks immune checkpoints to improve antigen presentation and T cell activation.
03
Biological functions
Antigen presentationT cell activationImmune surveillanceTumor cell recognition
04
Disease associations
CancerImmune evasionTumor immunity
05
Safety considerations
Off-target effects of immunotherapiesCytokine release syndrome (CRS)Immune-related adverse events (irAEs)Tumor lysis syndrome
06
Interacting drugs
Cancer vaccines
2 more in the full profile.
07
Biomarkers
MHC Class I expression levelsMHC Class II expression levelsTAA-specific T cell responsesTumor mutational burden (TMB)Microsatellite instability (MSI)
Beyond the preview
Go deeper on Tumor-Associated Antigen Presented by Major Histocompatibility Complex (TAA-MHC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor-Associated Antigen Presented by Major Histocompatibility Complex (TAA-MHC).